Genomics Informatics — Data elements and their metadata for describing structured clinical genomic sequence information in electronic health records
Introduction: Based on the rapid advancement of sequencing technologies, clinical sequencing has been highlighted as one of methods to realize genomic medicine, personalized medicine and precision medicine. There are lots of sequencing data in the public domain with clinical information.[13] In addition, genome-scale clinical sequencing is being adopted broadly in medical practice.[14] Many hospitals have started to sequence patients' whole genome, whole exome, or targeted genes using the next-generation sequencing technologies. These genomic data obtained by next-generation sequencing technologies can be used for both clinical purposes, to diagnose patients and choose the right medications, and research purposes. Therefore, the management of genomic and clinical data are increasingly highlighted in precision medicine, clinical trial, and translational research.[15] However, until now, there is no international standard for representing clinical sequencing results with a structured format for electronic health records. Consequently, the necessary genomic test results are not efficiently delivered to the clinicians. There are a few related standards for modelling genetic testing results (i.e. ISO 25720 and several HL7 documents from HL7 clinical genomics working group). However, these standards or drafts are mainly focused on the traditional genetic testing results for a single gene test. Based on the rapid development and adoption of next-generation sequencing techniques which can detect d
Scope: The document defines the data elements and the requisite metadata essential for implementing a structured clinical genomic sequencing report in electronic health records, particularly focusing on the genomic data generated by next-generation sequencing technology. This document: — defines the composition of a structured clinical sequencing report (see Clause 6); — defines the required data fields and their metadata for a structured clinical sequencing report (see Clause 7); — defines the optional data (see Clause 8); — covers the DNA-level variation from human samples using whole genome sequencing, whole exome sequencing, and targeted sequencing (disease-targeted gene panels) by next-generation sequencing technologies (though whole transcriptome sequencing and other technologies are important to provide better patient care and enable precision medicine, this document only deals with DNA-level changes); — covers mainly clinical applications and clinical research such as clinical trials and translational research which uses clinical data (basic research and other scientific areas are outside the scope of this document); — does not cover the other biological species, i.e. genomes of viruses and microbes; — does not cover the Sanger sequencing methods.